Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Operating Expenses | 8,395 | 7,948 | 6,466 | 1,410 | 3,411 |
| Operating Income | -8,395 | -7,948 | -6,466 | -1,410 | -3,411 |
| Interest Expense | 0 | 0 | 0 | -100 | 194 |
| Other Income | 61 | 12 | -4,638 | -180 | 0 |
| Pre-tax Income | -8,334 | -7,936 | -11,104 | -1,490 | -3,604 |
| Net Income Continuous | -8,334 | -7,936 | -11,104 | -1,477 | -3,604 |
| Net Income | $-8,334 | $-7,936 | $-11,104 | $-1,477 | $-3,604 |
| EPS Basic Total Ops | -23.04 | -23.04 | -53.12 | -57.60 | -151.68 |
| EPS Basic Continuous Ops | -23.23 | -22.85 | -53.26 | -57.70 | -151.66 |
| EPS Diluted Total Ops | -23.04 | -23.04 | -53.12 | -57.60 | -151.68 |
| EPS Diluted Continuous Ops | -23.23 | -22.85 | -53.26 | -57.70 | -151.66 |
| EBITDA(a) | $-8,389 | $-7,944 | $-5,694 | $-1,234 | $-3,367 |